Journal of Medicinal Chemistry p. 1523 - 1540 (2019)
Update date:2022-08-17
Topics:
Wang, Hui-Ling
Andrews, Kristin L.
Booker, Shon K.
Canon, Jude
Cee, Victor J.
Chavez, Frank
Chen, Yuping
Eastwood, Heather
Guerrero, Nadia
Herberich, Brad
Hickman, Dean
Lanman, Brian A.
Laszlo, Jimmy
Lee, Matthew R.
Lipford, J. Russell
Mattson, Bethany
Mohr, Christopher
Nguyen, Yen
Norman, Mark H.
Pettus, Liping H.
Powers, David
Reed, Anthony B.
Rex, Karen
Sastri, Christine
Tamayo, Nuria
Wang, Paul
Winston, Jeffrey T.
Wu, Bin
Wu, Qiong
Wu, Tian
Wurz, Ryan P.
Xu, Yang
Zhou, Yihong
Tasker, Andrew S.
Pim kinases are a family of constitutively active serine/threonine kinases that are partially redundant and regulate multiple pathways important for cell growth and survival. In human disease, high expression of the three Pim isoforms has been implicated in the progression of hematopoietic and solid tumor cancers, which suggests that Pim kinase inhibitors could provide patients with therapeutic benefit. Herein, we describe the structure-guided optimization of a series of quinazolinone-pyrrolodihydropyrrolone analogs leading to the identification of potent pan-Pim inhibitor 28 with improved potency, solubility, and drug-like properties. Compound 28 demonstrated on-target Pim activity in an in vivo pharmacodynamic assay with significant inhibition of BAD phosphorylation in KMS-12-BM multiple myeloma tumors for 16 h postdose. In a 2-week mouse xenograft model, daily dosing of compound 28 resulted in 33% tumor regression at 100 mg/kg.
View MoreDaqing New Century Fine Chemical Co., Ltd.
Contact:010-57126694
Address:No.39, jinxing cun, honggang district
Contact:86-574-26865651
Address:529 YuanBaoShan Road, Beilun District
Chemsky(shanghai)International Co.,Ltd.
Contact:0
Address:0
Contact:86-898-65311214
Address:Room 102, BLDG. 68 Jiangnan City, No. 66 Heping Road,Haikou, Hainan, China
AUSHUN PHARMACEUTICAL TECHNOLOGY CO,.LTD
Contact:+86-25-86883560 15951806178
Address:14 Dayingbi, Zhujiang Rd. East, Nanjing, Jiangsu, China.
Doi:10.1002/ejoc.200300059
(2003)Doi:10.1007/s10562-021-03581-0
(2021)Doi:10.3184/174751912X13379433093990
(2012)Doi:10.1007/s11172-016-1451-7
(2016)Doi:10.1016/S0040-4039(02)02264-5
(2002)Doi:10.1246/bcsj.41.1977
(1968)